Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

837 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response to letter regarding article, "Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a randomized evaluation of long-term anticoagulation therapy (RE-LY) substudy".
Hijazi Z, Oldgren J, Wallentin L, Andersson U, Connolly SJ, Yusuf S, Ezekowitz MD, Hohnloser SH, Reilly PA, Vinereanu D, Siegbahn A. Hijazi Z, et al. Among authors: wallentin l. Circulation. 2013 Jan 15;127(2):e278-9. doi: 10.1161/circulationaha.112.133546. Circulation. 2013. PMID: 23437443 No abstract available.
N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
James SK, Lindahl B, Siegbahn A, Stridsberg M, Venge P, Armstrong P, Barnathan ES, Califf R, Topol EJ, Simoons ML, Wallentin L. James SK, et al. Among authors: wallentin l. Circulation. 2003 Jul 22;108(3):275-81. doi: 10.1161/01.CIR.0000079170.10579.DC. Epub 2003 Jul 7. Circulation. 2003. PMID: 12847065 Clinical Trial.
Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy).
James SK, Lindahl B, Timmer JR, Ottervanger JP, Siegbahn A, Stridsberg M, Armstrong P, Califf R, Wallentin L, Simoons ML. James SK, et al. Among authors: wallentin l. Am J Cardiol. 2006 Jan 15;97(2):167-72. doi: 10.1016/j.amjcard.2005.08.036. Epub 2005 Nov 21. Am J Cardiol. 2006. PMID: 16442356
Soluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome.
Mälarstig A, Lindahl B, Wallentin L, Siegbahn A. Mälarstig A, et al. Among authors: wallentin l. Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1667-73. doi: 10.1161/01.ATV.0000222908.78873.36. Epub 2006 Apr 20. Arterioscler Thromb Vasc Biol. 2006. PMID: 16627810 Clinical Trial.
837 results